191 related articles for article (PubMed ID: 36787445)
1. Nonalcoholic Fatty Liver Disease Severity Is Related to Plasma Pro-Oxidative Biomarkers Rather Than Liver Tissue-Measured Nitrogen Metabolism Biomarkers in Population with Obesity and Metabolic Syndrome.
Suárez-Cuenca JA; Domínguez-Pérez GA; Hernández-Muñóz RE; Hernández-Patricio A; Vera-Gómez E; Gutiérrez-Buendía JA; Salamanca-García M; Montoya-Ramírez J; Gaytán-Fuentes OF; Aranda-Rodríguez C; Rojas-Noverón AR; García S; Mondragón-Terán P
Metab Syndr Relat Disord; 2023 Mar; 21(2):115-121. PubMed ID: 36787445
[No Abstract] [Full Text] [Related]
2. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
Lonardo A; Mantovani A; Lugari S; Targher G
Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia as an effect modifier of the association between metabolic phenotypes and nonalcoholic fatty liver disease in Chinese population.
Zheng J; Li X; Zhang Y; Miao Y; Zhang Q
J Transl Med; 2023 Jan; 21(1):39. PubMed ID: 36681819
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride glucose index, pediatric NAFLD fibrosis index, and triglyceride-to-high-density lipoprotein cholesterol ratio are the most predictive markers of the metabolically unhealthy phenotype in overweight/obese adolescent boys.
Furdela V; Pavlyshyn H; Shulhai AM; Kozak K; Furdela M
Front Endocrinol (Lausanne); 2023; 14():1124019. PubMed ID: 37234798
[TBL] [Abstract][Full Text] [Related]
5. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity.
Ampuero J; Aller R; Gallego-Durán R; Banales JM; Crespo J; García-Monzón C; Pareja MJ; Vilar-Gómez E; Caballería J; Escudero-García D; Gomez-Camarero J; Calleja JL; Latorre M; Albillos A; Salmeron J; Aspichueta P; Lo Iacono O; Francés R; Benlloch S; Fernández-Rodríguez C; García-Samaniego J; Estévez P; Andrade RJ; Turnes J; Romero-Gómez M;
Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1260-1270. PubMed ID: 30353552
[TBL] [Abstract][Full Text] [Related]
6. Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis.
Kim D; Kim W; Joo SK; Han J; Kim JH; Harrison SA; Younossi ZM; Ahmed A
J Gastroenterol; 2020 Mar; 55(3):330-341. PubMed ID: 31535207
[TBL] [Abstract][Full Text] [Related]
7. Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects.
Esteghamati A; Aryan Z; Esteghamati A; Nakhjavani M
Diabetes Metab; 2014 Nov; 40(5):347-55. PubMed ID: 24811744
[TBL] [Abstract][Full Text] [Related]
8. The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study.
Kouvari M; Chrysohoou C; Skoumas J; Pitsavos C; Panagiotakos DB; Mantzoros CS;
Metabolism; 2022 Mar; 128():154893. PubMed ID: 34600906
[TBL] [Abstract][Full Text] [Related]
9. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
11. Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.
Barchetta I; Cimini FA; Leonetti F; Capoccia D; Di Cristofano C; Silecchia G; Orho-Melander M; Melander O; Cavallo MG
J Clin Endocrinol Metab; 2018 Jun; 103(6):2253-2260. PubMed ID: 29590379
[TBL] [Abstract][Full Text] [Related]
12. Association between obesity phenotypes and non-alcoholic fatty liver: a large population- based study.
Najafi F; Pasdar Y; Nazar MM; Darbandi M
BMC Endocr Disord; 2024 Jun; 24(1):96. PubMed ID: 38918729
[TBL] [Abstract][Full Text] [Related]
13. Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
Man S; Lv J; Yu C; Deng Y; Yin J; Wang B; Li L; Liu H
Hepatol Int; 2022 Dec; 16(6):1412-1423. PubMed ID: 35987840
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
Lim S; Taskinen MR; Borén J
Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and cardiometabolic biomarkers in patients with non-alcoholic fatty liver disease.
Klisic A; Kavaric N; Ninic A; Kotur-Stevuljevic J
Sci Rep; 2021 Sep; 11(1):18455. PubMed ID: 34531465
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
[TBL] [Abstract][Full Text] [Related]
17. Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population.
Kuang M; Lu S; Xie Q; Peng N; He S; Yu C; Qiu J; Sheng G; Zou Y
BMC Gastroenterol; 2022 Jun; 22(1):311. PubMed ID: 35752753
[TBL] [Abstract][Full Text] [Related]
18. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects.
Kim SS; Cho HJ; Kim HJ; Kang DR; Berry JR; Kim JH; Yang MJ; Lim SG; Kim S; Cheong JY; Cho SW
Dig Liver Dis; 2018 Apr; 50(4):370-377. PubMed ID: 29398414
[TBL] [Abstract][Full Text] [Related]
20. Insulin Resistance Is the Main Characteristic of Metabolically Unhealthy Obesity (MUO) Associated with NASH in Patients Undergoing Bariatric Surgery.
Schmitz SM; Storms S; Koch A; Stier C; Kroh A; Rheinwalt KP; Schipper S; Hamesch K; Ulmer TF; Neumann UP; Alizai PH
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]